Trials / Withdrawn
WithdrawnNCT01074918
Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients
Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients; Role of Natriuresis
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Texas Southwestern Medical Center · Academic / Other
- Sex
- All
- Age
- 21 Years – 95 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to compare the effects of Potassium Magnesium Citrate to Potassium Chloride on blood pressure among patients with pre-hypertension or mild hypertension. We will also test whether Potassium Magnesium Citrate increases excretion of large amounts of sodium in the urine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Potassium, Magnesium, Citrate | Potassium MAgnesium Citrate - 30 mEq potassium, 15 mEq Magnesium, 45 mEq Citrate in a powder mixture twice a day, mixed with a glass of water. |
| DRUG | Potassium Chloride | Potassium Chloride |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2012-09-01
- Completion
- 2012-12-01
- First posted
- 2010-02-24
- Last updated
- 2019-02-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01074918. Inclusion in this directory is not an endorsement.